checkAd
    Startseite > Aktien > IN8bio > Nachrichten
    IN8bio Aktie
    1,0100
     
    USD
    -2,88 %
    -0,0300 USD
    Letzter Kurs 02:00:00 Nasdaq
    0,9900
     
    USD
    700 STK
    Geldkurs 29.04.24
    1,0100
     
    USD
    1.100 STK
    Briefkurs 29.04.24
    ISIN: US45674E1091 · WKN: A2QF49 · SYM: INAB · USA

    Neueste Nachrichten

    IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
    24.04.24 · globenewswire · IN8bio
    IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
    16.04.24 · globenewswire · IN8bio
    IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
    09.04.24 · globenewswire · IN8bio
    IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
    14.03.24 · globenewswire · IN8bio
    IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024
    05.03.24 · globenewswire · IN8bio
    IN8bio to Present at Upcoming Investor Conferences
    26.02.24 · Business Wire (engl.) · IN8bio
    IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology
    14.02.24 · globenewswire · IN8bio
    IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals
    04.01.24 · globenewswire · IN8bio
    IN8bio’s INB-200 Demonstrates Extended Progression-Free Survival in Patients with Newly Diagnosed Glioblastoma
    20.11.23 · globenewswire · IN8bio
    IN8bio to Present Data Highlighting Potential of INB-200 and INB-400 to Treat Patients with Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 28th Annual Meeting
    10.11.23 · globenewswire · IN8bio
    IN8bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
    09.11.23 · globenewswire · IN8bio
    IN8bio Presents Biologic Correlative Data from the INB-200 Phase 1 Trial in Newly Diagnosed Glioblastoma at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
    06.11.23 · globenewswire · IN8bio